Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kiromic BioPharma Inc.

    OTC: KRBP · Real-Time Price · USD
    0.20
    0.00 (0.05%)
    At close: Mar 24, 2025, 3:59 PM

    Kiromic BioPharma Statistics

    Share Statistics

    Kiromic BioPharma has 2.65M shares outstanding. The number of shares has increased by 72.03% in one year.

    Shares Outstanding

    n/a
    		 2.65M

    Shares Change (YoY)

    n/a
    		 72.03%

    Shares Change (QoQ)

    n/a
    		 71.64%

    Owned by Institutions (%)

    n/a
    		 4.93%

    Shares Floating

    n/a
    		 1.18M

    Failed to Deliver (FTD) Shares

    n/a
    		 659

    FTD / Avg. Volume

    n/a
    		 8.55%

    Short Selling Information

    The latest short interest is 45.74K, so undefined% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 45.74K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 4.09%

    Short Ratio (days to cover)

    n/a
    		 1.45

    Valuation Ratios

    The PE ratio is -0.87 and the forward PE ratio is -0.52. Kiromic BioPharma's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.87

    Forward PE

    n/a
    		 -0.52

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -1.86

    P/FCF Ratio

    n/a
    		 -1.18

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Kiromic BioPharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.16, with a Debt / Equity ratio of -1.16.

    Current Ratio

    n/a
    		 0.16

    Quick Ratio

    n/a
    		 0.16

    Debt / Equity

    n/a
    		 -1.16

    Debt / EBITDA

    n/a
    		 -0.61

    Debt / FCF

    n/a
    		 -0.73

    Interest Coverage

    n/a
    		 6.39

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-611,318.18

    Employee Count

    n/a
    		 44

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -93.53% in the last 52 weeks. The beta is 1.66, so Kiromic BioPharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.66

    52-Week Price Change

    n/a
    		 -93.53%

    50-Day Moving Average

    n/a
    		 1.06

    200-Day Moving Average

    n/a
    		 1.37

    Relative Strength Index (RSI)

    n/a
    		 24.45

    Average Volume (20 Days)

    n/a
    		 7,709

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -23.77M

    Net Income

    n/a
    		 -26.9M

    EBITDA

    n/a
    		 -23.77M

    EBIT

    n/a
    		 -30.62M

    Earnings Per Share (EPS)

    n/a
    		 -1.03
    Full Income Statement

    Balance Sheet

    The company has 1.14M in cash and 14.57M in debt, giving a net cash position of -13.43M.

    Cash & Cash Equivalents

    n/a
    		 1.14M

    Total Debt

    n/a
    		 14.57M

    Net Cash

    n/a
    		 -13.43M

    Retained Earnings

    n/a
    		 -149.79M

    Total Assets

    n/a
    		 8.54M

    Working Capital

    n/a
    		 -17.6M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -19.46M and capital expenditures -366K, giving a free cash flow of -19.82M.

    Operating Cash Flow

    n/a
    		 -19.46M

    Capital Expenditures

    n/a
    		 -366K

    Free Cash Flow

    n/a
    		 -19.82M

    FCF Per Share

    n/a
    		 -0.76
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    KRBP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for KRBP.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Mar 13, 2023. It was a backward split with a ratio of 1:30.

    Last Split Date

    n/a
    		 Mar 13, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:30

    Scores

    Altman Z-Score

    n/a
    		 -35.95

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist